National Institutes of Biomedical Innovation; Health and Nutrition
发明人:
Ken Ishii,Taiki Aoshi,Kouji Kobiyama
申请号：
US15539627
公开号：
US20180256630A1
申请日:
2014.12.26
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention provides an anticancer agent to be used as a single agent. More specifically, the present invention provides an anticancer agent containing complexes that contain (a) an oligodeoxynucleotide containing a humanized K-type CpG oligodeoxynucleotide and polydeoxyadenylic acid, the polydeoxyadenylic acid being located on the 3′ side of the humanized K-type CpG oligodeoxynucleotide, and (b) β-1,3-glucan. The present invention is preferably characterized in that the anticancer agent is administered without a cancer antigen.
